中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

42 records (took 0.018 seconds)

    Hypodermic injection device having cannula covered with resilient sheath
    1.
    发明授权
    Hypodermic injection device having cannula covered with resilient sheath 失效
    皮下注射装置具有用弹性护套覆盖的插管

    公开(公告)号：US3882863A

    公开(公告)日：1975-05-13

    申请号：US38468273

    申请日：1973-08-01

    Applicant: SURVIVAL TECHNOLOGY

    Inventor： SARNOFF STANLEY J ,  CALKINS GEORGE B

    IPC: A61M5/20 ,  A61M5/32

    CPC classification number: A61M5/2033 ,  A61M5/32 ,  A61M2005/206 ,  A61M2005/2073

    Abstract: A hypodermic injection device comprising a cartridge holder having a cylindrical body open at one end and closed at the other end, the closed end being provided with an aperture, a cartridge including an ampoule with attached cannula within the holder, the cannula being directed toward the holder''s closed end, the ampoule including a cylindrical sleeve slidably carrying a piston, the sleeve being open at one end and having a necked portion at the other end to receive a hub mounting the cannula, fluid medicament in the sleeve between the piston and cannula, a spring power assembly for moving the cartridge forward and for injecting the fluid medicament carried in the ampoule, a safety assembly for controlling actuation of the spring power assembly, and a resilient sheath covering the cannula to maintain the cannula in sterile condition.

    Abstract translation: 一种皮下注射装置，其包括具有在一端开口并在另一端封闭的圆筒体的药筒保持器，所述封闭端设有孔，所述药筒包括具有附着的插管的安瓿，所述套管指向所述保持器 保持器的封闭端，安瓿包括可滑动地携带活塞的圆柱形套筒，套筒在一端开口并且在另一端处具有颈部，以容纳安装插管的套筒，套筒中的流体药剂在活塞与套管之间， 弹簧动力组件，其用于向前移动暗盒并用于注射在安瓿中携带的流体药物，用于控制弹簧动力组件的致动的安全组件，以及覆盖套管以将插管维持在无菌状态的弹性护套。

    Large capacity syringe
    2.
    发明授权
    Large capacity syringe 失效
    大容量注射器

    公开(公告)号：US3895633A

    公开(公告)日：1975-07-22

    申请号：US40127273

    申请日：1973-09-27

    Applicant: SURVIVAL TECHNOLOGY

    Inventor： BARTNER ELLIOT ,  CURLEY EDWARD M ,  KAPLAN SHELDON ,  SARNOFF STANLEY J

    IPC: A61M5/178 ,  A61M5/24 ,  A61M5/28 ,  A61M5/315 ,  A61M5/26 ,  A61M5/32

    CPC classification number: A61M5/24 ,  A61M5/178 ,  A61M5/285 ,  A61M5/31505 ,  A61M2005/2407 ,  A61M2005/247

    Abstract: A syringe adapted to inject substantial amounts of medicament, said syringe comprising a syringe barrel having a necked portion at one end with a central through-bore while the other end is open and provided with a peripheral flange. A cannula assembly is fixedly fitted into the necked end of the syringe barrel, said cannula assembly including a body portion fixedly fitting into the necked portion of the syringe barrel with a cannula extending outwardly therefrom. A cylindrical needle support extends rearwardly from the body and mounts a needle within the syringe barrel. A cartridge assembly is slidably carried within the syringe barrel and includes a cylindrical cartridge body having a necked end closed by a stopper. The open end of the cylindrical body is closed off by a plunger whereby the medicament is held between the stopper and the plunger. The necked end of the cartridge body mounts a cap having an outwardly extending sleeve sized to fit over the needle support. Interengaging positioning portions are provided on the sleeve and needle support to lock the cartridge assembly in inactivated and actuated position. A retaining clip fits over the open end of the syringe barrel to retain the cartridge assembly within said barrel.

    Abstract translation: 一种适于注射大量药物的注射器，所述注射器包括注射器筒，所述注射器筒的一端具有中心通孔的颈缩部分，而另一端开放并设有周边凸缘。 插管组件固定地装配到注射器筒的颈缩端部中，所述插管组件包括主体部分，该主体部分固定地装配到注射器筒的颈缩部分中，并具有从其向外延伸的套管。 圆柱形针支撑件从主体向后延伸并将针安装在注射器筒内。 药筒组件可滑动地携带在注射器筒内，并且包括圆柱形药筒本体，颈部端部由塞子封闭。 圆柱体的开口端由柱塞封闭，由此药物保持在止动器和柱塞之间。 药筒本体的颈部端部安装有具有向外延伸的套筒的盖，其尺寸适于装配在针支撑件上。 入口定位部分设置在套筒和针支撑件上以将盒组件锁定在非激活和致动位置。 保持夹配合在注射器筒的开口端上，以将筒组件保持在所述筒内。

    Tip assembly for syringes
    3.
    发明授权
    Tip assembly for syringes 失效
    注射器的头组件

    公开(公告)号：US3889673A

    公开(公告)日：1975-06-17

    申请号：US42985074

    申请日：1974-01-02

    Applicant: SURVIVAL TECHNOLOGY

    Inventor： DOVEY BRIAN H ,  BARTNER ELLIOT ,  KAPLAN SHELDON ,  SARNOFF STANLEY J

    IPC: A61M5/31 ,  A61M5/32

    CPC classification number: A61M5/31 ,  A61M5/3202

    Abstract: A tip assembly for a syringe wherein the assembly includes a cylindrical main body having an open forward end and a partially closed back end. The inner surface of the main body adjacent the back end has an annular seal. An inner cylindrical body is positioned within and coaxial with the main body forwardly of the annular seal. A flange-like member connects the inner body to the main body to retain the inner body in spaced relation within the main body. A cap is provided for closing the open end of the main body. A needle assembly is supported by the inner body within the main body. This needle assembly has a hub with a hole extending therethrough. A needle is held in the forward portion of the hub and a portion of the hub rearwardly of the needle is sized to fit in the inner body to position the needle assembly within the main body.

    Abstract translation: 一种用于注射器的尖端组件，其中所述组件包括具有敞开的前端和部分封闭的后端的圆柱形主体。 靠近后端的主体的内表面具有环形密封。 内圆柱体位于环形密封件前方与主体同轴。 凸缘状构件将内体连接到主体以将内体保持在主体内的间隔关系。 提供盖以封闭主体的开口端。 针组件由主体内的主体支撑。 该针组件具有带有延伸穿过其中的孔的轮毂。 针被保持在轮毂的前部，并且针的后部的轮毂的一部分的尺寸被设计成装配在内部主体中以将针组件定位在主体内。

    Method and apparatus of treating heart attack patients prior to the establishment of qualified direct contact personal care
    4.
    发明授权
    Method and apparatus of treating heart attack patients prior to the establishment of qualified direct contact personal care 失效
    在建立合格的直接接触个人护理之前，对心脏病患者进行治疗的方法和装置

    公开(公告)号：US3910260A

    公开(公告)日：1975-10-07

    申请号：US41812573

    申请日：1973-11-21

    Applicant: SURVIVAL TECHNOLOGY

    Inventor： SARNOFF STANLEY J ,  REINHOLD JR HERBERT E

    IPC: A61B5/00 ,  A61B5/0404 ,  A61B5/04

    CPC classification number: A61B5/411 ,  A61B5/0006 ,  A61B5/0404 ,  Y10S128/904

    Abstract: A method of treating coronary prone individuals between the time that heart attack symptoms occur and qualified direct contact personal care can be administered which comprises providing each of a multiplicity of coronary prone individuals with (1) a plurality of separate medicaments, such as atropine and lidocaine, in self-administering form, such as automatic injectors, and (2) a portable battery operated device having a pair of electrodes shaped to fit within the armpits and means to provide auditory signals indicative of the existing heart beat conditions including signals corresponding to the electrical activity of the heart, establishing communication by telephone between any of the individuals experiencing heart attack symptoms and a source including a plurality of individuals available at all times at specific telephones having medical records of each of the individuals immediately available, including standing orders of each individual''s doctor, and outgoing telephones for notifying the individual''s doctor and next-of-kin and for dispatching an ambulance to the individual, positioning the electrodes within the armpits of the individual and communicating the signals thus provided to the qualified source by means of the established telephone communication, including transmitting thereover the electrical heart activity signals, receiving the signals and converting them to wave form oscilloscope pictures and electrocardiograms, communicating by means of the established telephone communication a qualified response determined from the information obtained at the source and administering responsive medicament to the individual at a time prior to the establishment of qualified direct contact personal care.

    Abstract translation: 可以施用在发生心脏病发作症状的时间和合格的直接接触个人护理之间治疗冠心病患者的方法，其包括为多个冠状动脉易发个体提供（1）多种分开的药物，例如阿托品和利多卡因 （例如自动注射器），以及（2）一种便携电池操作的装置，其具有一对形状适合于腋窝内的电极，以及提供指示现有心跳条件的听觉信号的装置，包括对应于 心脏的电活动，在经历心脏病发作症状的任何个体之间通过电话建立通信，包括在具有可立即可用的每个人的医疗记录的特定电话机上随时可用的多个个体的来源，包括每个 个人的医生，以及外出电话 如果个人的医生和亲属，并且为个人派遣救护车，将电极定位在个体的腋窝内，并通过建立的电话通信将所提供的信号传送到合格的来源，包括在其上传送 电心脏活动信号，接收信号并将其转换成波形示波器图像和心电图，通过建立的电话通信进行通信，根据从源获得的信息确定的合格响应，并在第一时间之前向个体施用反应性药物 建立合格的直接接触个人护理。

    Method and apparatus for self-administering pre-hospital phase treatment of coronary prone individuals in the early minutes or hours after the onset of heart attack symptoms
    5.
    发明授权
    Method and apparatus for self-administering pre-hospital phase treatment of coronary prone individuals in the early minutes or hours after the onset of heart attack symptoms 失效
    在心跳攻击症状开始后的早期或时间内自我管理冠状动脉疾病个体的预处理方法和装置

    公开(公告)号：US3870035A

    公开(公告)日：1975-03-11

    申请号：US29684172

    申请日：1972-10-12

    Applicant: SURVIVAL TECHNOLOGY

    Inventor： SARNOFF STANLEY J

    IPC: A61B5/00 ,  A61B5/024 ,  A61B5/02

    CPC classification number: A61B5/0002 ,  A61B5/024 ,  A61B5/02438 ,  Y10S128/904

    Abstract: Method for self-administering prehospital phase treatment of coronary prone individuals during the early minutes or hours after the onset of heart attack symptoms and apparatus for use therein. The apparatus comprises the combination of a portable battery-operated device having circuitry operable when operatively connected with an individual to produce audible signals capable of telephone transmission in the form of a beep corresponding with each heart beat of the individual and rate range signal in the form of different colored lights each corresponding to a predetermined rate range and a plurality of different automatic injectors each color-coded to the signal lights and containing different medicaments which are effective within the corresponding rate range and may be adversely effective outside the corresponding rate range. The method includes performing the following steps within the early minutes or hours after the onset of heart attack symptoms: (1) obtaining access to the apparatus, (2) establishing an operative connection between the device and the individual, (3) producing the signals, (4) utilizing the signals to determine the injector containing the medicament effective under the existing heart beat conditions, (5) identifying the applicable injector and (6) selfadministering the injector to inject the medicament therefrom into the individual.

    Abstract translation: 在心脏病发作症状发作的早期分钟或数小时内，对冠心病患者进行院前相治疗的方法及使用方法。 该装置包括便携式电池供电设备的组合，其具有可操作地与个人操作连接的电路，以产生能够以对应于个体的每个心跳的形式的电话传输的声音信号，以及形式的速率范围信号 每个对应于预定速率范围的不同颜色的灯和多个不同的自动喷射器，每个颜色编码到信号灯并且包含在相应的速率范围内有效的不同药物，并且可能在对应的速率范围之外是有害的。 该方法包括在心脏病发作症状发作后的早几分钟或几小时内执行以下步骤：（1）获得对该装置的访问，（2）建立装置与个体之间的有效连接，（3）产生信号 （4）利用这些信号来确定含有在现有心跳条件下有效的药物的注射器，（5）识别适用的注射器，以及（6）自主施用注射器以将药物从其中注入个体。

    INITIATING REPERFUSION TREATMENT WHEN HEART ATTACK SYMPTOMS ARE PRESENT
    8.
    发明专利
    INITIATING REPERFUSION TREATMENT WHEN HEART ATTACK SYMPTOMS ARE PRESENT 未知

    公开(公告)号：CA1265009A

    公开(公告)日：1990-01-30

    申请号：CA488318

    申请日：1985-08-08

    Applicant: SURVIVAL TECHNOLOGY

    Inventor： SARNOFF STANLEY J

    IPC: A61K38/00 ,  A61K31/13 ,  A61K31/15 ,  A61K31/155 ,  A61K31/17 ,  A61K31/415 ,  A61K31/66 ,  A61K31/80 ,  A61K38/38 ,  A61K38/44 ,  A61K38/49 ,  A61K45/06 ,  A61K47/00 ,  A61K47/18 ,  A61M5/19 ,  A61M5/20 ,  A61N1/375

    Abstract: INITIATING REPERFUSION TREATMENT WHEN HEART ATTACK SYMPTOMS ARE PRESENT A device for initiating reperfusion treatment of a coronary prone individual prior to the establishment of qualified direct contact personal care at a time during the early minutes or hours after the onset of heart attack symptoms and after qualified personnel have participated by telephone in the decision to initiate such treatment. The device comprises an automatic injector assembly (12) including a releasable force applying assembly, (32 and 34) a safety (128,130 and 132) normally disposed in a release preventing position movable therefrom into a release permitting position, a container or containers (44 and 96) for separately containing a plurality of separate medicament dosages including a first dosage (52) containing a clot selective coronary thrombolytic agent and a separate second dosage (98) containing a cardiac antiarrhythmic agent and one or more hypodermic needles (48 and 102). The automatic injector is operable in response to a predetermined manual actuating procedure including the movement of the safety into its release permitting position for effecting release of the releasable force applying assembly and causing the released force to be applied so as to effect (1) the movement of the hypodermic needle or needles into the muscle tissue of the individual and (2) the flow of the separate medicament dosages outwardly from the container or containers through the hypodermic needle or needles into the muscle tissue of the individual.

Patent Agency Ranking